Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir and HBIG to prevent HBV recurrence after liver transplant
NCT02417207Phase 4Unknown
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Apr 2015
- Primary completion
- Apr 2018
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis B immune globulin in hepatitis B (HBV), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Status: unknown.
02
Drugs
hepatitis B immune globulin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02417207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02417207.